Sec. 1087. Assessment regarding eligibility for compensation for compensable diseases under the Radiation Exposure Compensation Act
211 words·~1 min read·
/bill/115/hr/5515/eh/section-1087·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The National Cancer Institute and the Centers for Disease Control and Prevention shall assess the application of probability of causation/assigned share (in this section referred to as PC/AS ) to determine eligibility for compensation for compensable diseases under the Radiation Exposure Compensation Act ( Public Law 101–426 ; 42 U.S.C. 2210 note) in downwind populations in the continental United States, Alaska, Hawaii, and the possessions and territories of the United States.
To carry out the assessment, the National Cancer Institute and the Centers for Disease Control and Prevention shall, at a minimum— complete the work begun in the late 1990s to develop dose estimates for downwind populations in such locations from fallout from nuclear weapons testing by the United States; and estimate the portions of these downwind populations that could become eligible for compensation compensable diseases under such Act for each of the following PC/AS criteria:
Median PC/AS > 0.5. PC/AS > 0.5 at the 80 percent credibility limit. PC/AS > 0.5 at the 99 percent credibility limit. Not later than 60 days after the date of the enactment of this Act, the National Cancer Institute and the Centers for Disease Control and Prevention shall inform Congress of the time and resources required to carry out the assessment under subsection (a).
Connectionstraces to 1
Traces to 1 document
1 reference not yet in our index
- Pub. L. 101-426
Citation graph
cites case law
Sec. 1087
Assessment regarding eligibility for compensation for compensable diseases under the Radiation Exposure Compensation Act
Pub. L.Pub. L. 101-426
Cites 2Cited by 0 across 0 sources